Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal...

Area of Science:

• Neuroimmunology
• Molecular immunology
• Cellular immunology

Background:

• Chemokines are implicated in T-cell recruitment to the central nervous system (CNS) in multiple sclerosis (MS).
• Understanding chemokine receptor expression is crucial for elucidating T-cell migration in MS pathogenesis.

Purpose of the Study:

• To investigate the expression of Th1-related chemokine receptors CCR5 and CXCR3 in patients with MS.
• To compare receptor expression in MS patients with healthy controls (HC) and other non-inflammatory neurological disease (OND) patients.
• To assess the impact of interferon-beta (IFN-beta) treatment and optic neuritis (ON) on chemokine receptor expression.

Main Methods:

• Flow cytometry was used to quantify T cells expressing CCR5 and CXCR3.
• Analysis was performed on blood samples from MS patients, HC, and OND patients.
• Cerebrospinal fluid (CSF) samples were analyzed from MS and OND patients.

Main Results:

• Untreated MS patients showed higher percentages of CCR5 and CXCR3 expressing T cells in blood compared to HC.
• Elevated CCR5 and CXCR3 expressing T cells were observed in CSF of MS patients versus OND patients.
• MS patients undergoing IFN-beta treatment did not exhibit these elevated receptor percentages.
• Patients with optic neuritis (ON) had increased CXCR3+ T cells in blood and CCR5+ T cells in CSF.

Conclusions:

• Elevated CCR5 and CXCR3 expression on T cells may facilitate their migration into the CNS in MS.
• IFN-beta treatment might exert a therapeutic effect by inhibiting chemokine receptor expression.
• Chemokine receptor expression patterns in ON suggest early involvement in MS pathogenesis.